DrugPatentWatch Database Preview
Profile for United States of America Patent: 2015374630
US Patent Family Members and Approved Drugs for United States of America Patent: 2015374630
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Sep 15, 2025 | Endo Pharms | OPANA ER | oxymorphone hydrochloride |
➤ Try a Free Trial | Oct 10, 2024 | Depomed Inc | NUCYNTA ER | tapentadol hydrochloride |
➤ Try a Free Trial | Aug 8, 2024 | Endo Pharms | OPANA ER | oxymorphone hydrochloride |
➤ Try a Free Trial | Nov 20, 2023 | Depomed Inc | NUCYNTA ER | tapentadol hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |